Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
HCAT
$1.65
+3.77%
HCAT
· Health Catalyst, Inc.
Market Cap
$119.66M
Shares
75.26M
All earnings calls
Earnings call · FY2026 Q2
Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$70.49M
-12.7% YoY
Diluted EPS
-$0.55
Net income
-$40.54M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenue
Initiated
third quarter of 2026
|
$55M – $56M | GAAP | |
|
Adjusted EBITDA
Initiated
third quarter of 2026
|
$0 – $500,000 | Non-GAAP | |
|
Total revenue
Lowered
full year of 2026
|
$246M – $249M | GAAP | |
|
Adjusted EBITDA
Lowered
full year of 2026
|
$18M – $18.5M | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document